CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 40 enrolled
Drug / intervention
Epinephrin +2 moredrug
Likely dose
1% lidocaine with epinephrin 1:100,000 4 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05867342
NCT05867342Phase 4Completed

Effects of Adrenaline Infiltration on Surgical Field of View in Endoscopic Sinus Surgery

Stanford University·interventional·Posted May 22, 2023·Updated Jul 10, 2023

In Brief

A Phase 4 clinical trial evaluating Epinephrin, 1% lidocaine with epinephrin 1:100,000, and 1 other intervention for Intraoperative Bleeding. Completed, enrolled 40 participants across 1 site.

Detailed Summary

In endoscopic sinus surgery a clear surgical field of view is a very important aspect for good surgical outcome. This study is to evaluate the preoperative preparation to acquire best surgical field of view by comparing between the use of topical adrenaline and the use of combination of topical adrenaline with infiltration of 1% lidocaine with adrenaline in patients scheduled for endoscopic sinus surgery for rhinosinusitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedMay 22, 2023
Enrollment StartMay 12, 2017
Primary CompletionAug 22, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 3.1 years ago

Interventions

Epinephrindrug

Topical application of 2 pieces of Epinephrin (1:1,000)-soaked cottonoid in nasal cavity

1% lidocaine with epinephrin 1:100,000drug

4 ml intranasal infiltration of 1% lidocaine with epinephrine (1:100,000) at 2 sites (2 ml infiltration at each site)

Salinedrug

4 ml intranasal infiltration of saline at 2 sites (2 ml infiltration at each site)